Use of mesenchymal stem cells for treating genetic diseases and disorders
A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or disorder in the animal.
1 . A method of treating a genetic disease or disorder in an animal wherein said genetic disease or disorder is characterized by at least one of an inflamed tissue or organ of said animal, said method comprising:
administering to said animal mesenchymal stem cells in an amount effective to treat said genetic disease or disorder in said animal.
2 . The method of claim 1 wherein said genetic disease or disorder is cystic fibrosis.
3 . The method of claim 1 wherein said genetic disease or disorder is polycystic kidney disease.
4 . The method of claim 1 wherein said genetic disease or disorder is Wilson's disease.
5 . The method of claim 1 wherein said genetic disease or disorder is amyotrophic lateral sclerosis.
6 . The method of claim 1 wherein said genetic disease or disorder is Duchenne muscular dystrophy.
7 . The method of claim 1 wherein said genetic disease or disorder is Becker muscular dystrophy.
8 . The method of claim 1 wherein said genetic disease or disorder is Gaucher's disease.
9 . The method of claim 1 wherein said genetic disease or disorder is Parkinson's disease.
10 . The method of claim 1 wherein said genetic disease or disorder is Alzheimer's disease.
11 . The method of claim 1 wherein said genetic disease or disorder is Huntington's disease.
12 . The method of claim 1 wherein said genetic disease or disorder is Charcot-Marie-Tooth syndrome.
13 . The method of claim 1 wherein said genetic disease or disorder is Zellweger syndrome.
14 . The method of claim 1 wherein said genetic disease or disorder is autoimmune polyglandular syndrome.
15 . The method of claim 1 wherein said genetic disease or disorder is Marfan's syndrome.
16 . The method of claim 1 wherein said genetic disease or disorder is Werner syndrome.
17 . The method of claim 1 wherein said genetic disease or disorder is adrenoleukodystrophy.
18 . The method of claim 1 wherein said genetic disease or disorder is Menkes syndrome.
19 . The method of claim 1 wherein said genetic disease or disorder is malignant infantile osteopetrosis.
20 . The method of claim 1 wherein said genetic disease or disorder is spinocerebellar ataxia.
21 . The method of claim 1 wherein said genetic disease or disorder is spinal muscular atrophy.
22 . The method of claim 1 wherein said genetic disease or disorder is glucose galactose malabsorption.
23 . The method of claim 1 wherein said mesenchymal stem cells are administered intravenously.
24 . The method of claim 1 wherein said mesenchymal stem cells are administered intraosseously.
25 . The method of claim 1 wherein said mesenchymal stem cells are administered in an amount of from about 1×10 6 MSCs per kg of body weight to about 10×10 6 MSCs per kg of body weight.
26 . The method of claim 25 wherein said mesenchymal stem cells are administered in an amount of from about 4×10 6 MSCs per kg of body weight to about 8×10 6 MSCs per kg of body weight.
27 . The method of claim 1 wherein said animal is a human.